Drugs / FIRUGLIPEL
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT02790684 | May → Jun 2016 | — | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 1 | NCT02790671 | May → Jun 2016 | — | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 1 | NCT03699774 | May → Jul 2015 | — | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT02685345 | Jan → Sep 2016 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 2 | NCT02647320 | Jan 2016 → Jan 2017 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 2 | NCT02222350 | Jul → Nov 2014 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02669732 | Jan → Aug 2016 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
| — | NCT02628392 | Nov 2015 → Sep 2016 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FIRUGLIPEL | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314955 ↗ |
| Known as | DS-8500a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02790671 ↗ |
| Action | Activate | “G protein-coupled receptor 119 agonist” PMID 29071087 ↗ Sep 2017 |
| Modality | Small molecule | — CHEMBL5314955 ↗ |
| Route | Oral | “DS-8500a 10 mg and 75 mg administered orally, once daily, for 28 days” NCT02222350 ↗ |